News

This is Ask An Expert, where every weekday at 9:20am, KCBS Radio is giving you direct access to top experts in various fields. Today: Gene-editing technology allows scientists to work with DNA in unprecedented ways, but there are larger scientific...

For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.

Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...

Pronatalism is an old idea with roots in eugenics and nationalism, that is now fashionable among far-right influencers and policymakers. They talk...

This is the 10th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

By Jody Allard, Vice | 05.27.2016

The first time a doctor told me he had no idea what was wrong with me, I was six or...

By Martin Enserink, Science Magazine | 05.27.2016

In what European science chief Carlos Moedas calls a "life-changing" move, E.U. member states today agreed on an ambitious new open-access...

By Carl Zimmer, The New York Times | 05.27.2016

The history of African-Americans has been shaped in part by two great journeys.

The first brought hundreds of thousands of...

By Agence France-Presse, The Guardian | 05.27.2016

The Dutch government has announced it wants to allow growing human embryos “under strict and limited conditions” for scientific research...

By Joe Matthews (Zócalo Public Square), Huffington Post | 05.27.2016

Near the end of a wide-ranging conversation about the complexity of the human genome and the history and future of...

By Aaron Carroll (The Incidental Economist), Academy Health Blog | 05.27.2016

For many, many years we’ve been hearing about gene therapy – the chance that we can get into people’s DNA...

By Carl Zimmer, STAT | 05.26.2016
Untitled Document

At the American Museum of Natural History, the venerable Science Talent Search announced Thursday that it was changing...

By Antonio Regalado, MIT Technology Review | 05.25.2016

The biggest beneficiary of a plan to fabricate a human genome from scratch could be a Massachusetts startup called Gen9...